{"id":3661,"date":"2025-03-31T18:11:46","date_gmt":"2025-03-31T18:11:46","guid":{"rendered":"https:\/\/kidneydiseaseclinic.net\/kdc\/aciclovir-oral-txt\/"},"modified":"2025-03-31T18:11:46","modified_gmt":"2025-03-31T18:11:46","slug":"aciclovir-oral-txt","status":"publish","type":"post","link":"https:\/\/kidneydiseaseclinic.net\/kdc\/aciclovir-oral-txt\/","title":{"rendered":"Aciclovir oral.txt"},"content":{"rendered":"<h1>Aciclovir oral<\/h1>\n<p><H3>  CLINICAL USE <\/H3>Antiviral agent:<\/p>\n<li>Herpes simplex and herpes zoster  infection<H3> DOSE IN NORMAL RENAL FUNCTION  <\/H3>\n<li>Simplex treatment: 200\u2013400 mg 5 times  daily\n<li>Prophylaxis (immunocompromised):  200\u2013400 mg every 6 hours\n<li>Suppression: 200 mg every 6 hours, or  400 mg every 12 hours\n<li>Zoster: 800 mg 5 times a day for 7 days <H3>  PHARMACOKINETICS    <\/H3><LI> Molecular weight &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :225.2<\/li>\n<li>  %Protein binding  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp  &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :9\u201333<\/li>\n<li>  %Excreted unchanged in urine &amp;nbsp &amp;nbsp : 40\u201370<\/li>\n<p><LI> Volume of distribution (L\/kg) &amp;nbsp &amp;nbsp &amp;nbsp :0.7<\/li>\n<p><LI>half-life \u2013 normal\/ESRD (hrs)&amp;nbsp &amp;nbsp &amp;nbsp :2.9\/19.5 (dialysis: 5.7)<H3>  DOSE IN RENAL IMPAIRMENT <\/H3> <H4>GFR (mL\/MIN)<\/H4>25\u201350 Dose as in normal renal function 10\u201325 Simplex: 200 mg 3\u20134 times daily.  Zoster: 800 mg every 8\u201312 hours<LI> &lt;10 &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : Simplex: 200 mg every 12 hours. Zoster: 400\u2013800 mg every 12 hours<H3> DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES  <\/H3><LI> CAPD  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp:Not dialysed. Dose as in GFR &lt;10 mL\/min <\/p>\n<li> HD &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :Dialysed. Dose as in GFR<LI> &lt;10 &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : mL\/min. Give dose after dialysis<LI>HDF\/high flux  &amp;nbsp :Dialysed. Dose as in GFR<LI> &lt;10 &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : mL\/min. Give dose after dialysis<LI>CAV\/VVHD  &amp;nbsp &amp;nbsp &amp;nbsp:Dialysed. Dose as in GFR=10\u201320 mL\/min<H3> IMPORTANT DRUG INTERACTIONS  <\/H3>Potentially hazardous interactions with other drugs\n<li>Ciclosporin: reports of increase and  decrease in ciclosporin levels; some editors report no experience of interaction locally; possibly increased risk of nephrotoxicity.\n<li>Higher plasma levels of aciclovir and  mycophenolate mofetil with concomitant administration\n<li>Tacrolimus: possibly increased risk of  nephrotoxicity<H3> ADMINISTRATION  <\/H3><H4> Reconstition<\/H4>\u2013<H4>  Route  <\/H4>Oral <H4>  Rate of Administration  <\/H4>\u2013<H4>Comments<\/H4>Dispersible tablets may be dispersed in a  minimum of 50 mL of water or swallowed whole with a little water<H4>  OTHER INFORMATION  <\/H4>\n<li>Consider IV therapy for herpes  zoster infection if patient severely immunocompromised\n<li>Plasma aciclovir concentration is reduced  by 60% during haemodialysis<br \/>\n","protected":false},"excerpt":{"rendered":"<p>Aciclovir oral CLINICAL USE Antiviral agent: Herpes simplex and herpes<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7],"class_list":["post-3661","post","type-post","status-publish","format-standard","hentry","category-blog","tag-post-by-auto-php"],"_links":{"self":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/3661","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/comments?post=3661"}],"version-history":[{"count":0,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/3661\/revisions"}],"wp:attachment":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/media?parent=3661"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/categories?post=3661"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/tags?post=3661"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}